CompletedNCT00257166
Ziprasidone or placebo for mania or mixed episodes in young people with bipolarity
About this title
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Read the official source — NCT00257166Medication studyAges 10–17United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Scottsdale and 49 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJanuary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 238
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT00257166
- Official title
Show the full official title
Four Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Scottsdale · Orange · San Diego
41 more locations
- Denver
- Altamonte Springs
- Fort Lauderdale
- North Miami
- Orange City
- Tavares
- Decatur
- Honolulu
- Des Plaines
- Schaumburg
- Terre Haute
- Lexington
- Owensboro
- Baton Rouge
- Shreveport
- Pikesville
- Towson
- Clinton Township
- Meridian
- St Louis
- Lincoln
- Omaha
- Albuquerque
- Buffalo
- Rochester
- Cincinnati
- Cleveland
- Columbus
- Oklahoma City
- Tulsa
- Charleston
- Arlington
- DeSoto
- Fort Worth
- Lake Jackson
- Plano
- San Antonio
- Kirkland
- Spokane
- Milwaukee
- West Allis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Did this study involve medication?
Yes. The study involved medication, including Ziprasidone oral capsules and placebo oral capsules.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
